Octamoxin
From Wikipedia, the free encyclopedia
 |
|
| Names | |
|---|---|
| Preferred IUPAC name
1-Methylheptylhydrazine[citation needed]
|
|
| Systematic IUPAC name
Octan-2-ylhydrazine[1]
|
|
| Identifiers | |
4684-87-1  |
|
| 3D model (Jmol) | Interactive image |
| ChemSpider | 19587 |
| PubChem | 20811 |
| UNII | 0HXY3M6S54 |
|
|
|
|
| Properties | |
| C8H20N2 | |
| Molar mass | 144.26 g·mol−1 |
| Density | 0.831 g/mL |
| Boiling point | 228 °C (442 °F; 501 K) |
| Pharmacology | |
| Oral | |
| Related compounds | |
|
Related compounds
|
Tuaminoheptane |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
| Infobox references | |
Octamoxin (trade names Ximaol, Nimaol), also known as 2-octylhydrazine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class that was used as an antidepressant in the 1960s but is now no longer marketed.[2][3][4][5]
See also[edit]
References[edit]
- ^ "Octamoxin - Compound Summary". USA: National Center for Biotechnology Information. 26 March 2005. Identification and Related Records. Retrieved 31 May 2012.
- ^ "Dictionary of pharmacological agents - Google Books".
- ^ "13-06781. Octamoxin [Archived]: The Merck Index".
- ^ Levy J, Michel-Ber E (1966). "[Relations between the antidepressive effects of octamoxine revealed by 3 pharmacological tests and inhibition of cerebral monoamine oxidase in mice]". Thérapie (in French). 21 (4): 929–45. PMID 5925088.
- ^ Gayral L, Stern H, Puyuelo R (1966). "[Indications and results of the treatment of mental depression by octamoxine (ximaol)]". Thérapie (in French). 21 (5): 1183–90. PMID 5976767.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
